Asep Medical Holdings Inc
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnosti… Read more
Asep Medical Holdings Inc (SEPSF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.062x
Based on the latest financial reports, Asep Medical Holdings Inc (SEPSF) has a cash flow conversion efficiency ratio of -0.062x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-582.68K) by net assets ($9.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Asep Medical Holdings Inc - Cash Flow Conversion Efficiency Trend (2019–2023)
This chart illustrates how Asep Medical Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Asep Medical Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Asep Medical Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mühlbauer Holding AG
XETRA:MUB
|
0.114x |
|
MOBA Network publ AB
ST:MOBA
|
0.084x |
|
Oceansix Future Paths Ltd.
V:OSIX
|
0.474x |
|
Great Quest Fertilizer Ltd
PINK:GQMLF
|
0.774x |
|
Avio SpA
STU:2ZP
|
N/A |
|
OSX Brasil S.A
SA:OSXB3
|
-0.002x |
|
American Helium Inc
PINK:AHELF
|
0.251x |
|
Farmers Bancorp (Frankfort IN)
PINK:FABP
|
0.017x |
Annual Cash Flow Conversion Efficiency for Asep Medical Holdings Inc (2019–2023)
The table below shows the annual cash flow conversion efficiency of Asep Medical Holdings Inc from 2019 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $22.56 Million | $-2.71 Million | -0.120x | +11.68% |
| 2022-12-31 | $26.55 Million | $-3.61 Million | -0.136x | -249.43% |
| 2021-12-31 | $30.57 Million | $-1.19 Million | -0.039x | -126.51% |
| 2020-12-31 | $-150.53K | $-22.12K | 0.147x | -62.48% |
| 2019-12-31 | $-122.43K | $-47.96K | 0.392x | -- |